Tableting properties of freeze-dried trehalose: Physico-chemical and mechanical investigation.


Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
15 Dec 2023
Historique:
received: 12 10 2023
revised: 09 11 2023
accepted: 09 11 2023
medline: 5 12 2023
pubmed: 14 11 2023
entrez: 13 11 2023
Statut: ppublish

Résumé

Freeze-drying of biopharmaceutical products is the method of choice in order to improve their stability and storage conditions. Such freeze-dried products are usually intended for parenteral route administration. However, many biopharmaceutical materials administered by parenteral route are used to treat local diseases particularly in the gastro-intestinal tract. Therefore, many studies concentrate nowadays their effort on developing alternative dosage forms to deliver biopharmaceutical molecules by the oral route. Tablets are the most popular solid pharmaceutical dosage form used for oral administration since they present many advantages, but poor informations are available on the possibility of tableting freeze-dried powders. In this study, we evaluate the compaction behavior of freeze-dried trehalose powder since trehalose is one of the most used cryo and lyoprotectant for the lyophilisation of biopharmaceutical entities. Results show that freeze-dried trehalose powder can be tableted while remaining amorphous and the obtained compacts present very specific properties in terms of compressibility, tabletability, brittleness and viscoelasticity compared to the crystalline trehalose and compared to classical pharmaceutical excipients.

Identifiants

pubmed: 37956724
pii: S0378-5173(23)01019-0
doi: 10.1016/j.ijpharm.2023.123598
pii:
doi:

Substances chimiques

Trehalose B8WCK70T7I
Powders 0
Biological Products 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

123598

Informations de copyright

Copyright © 2023. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Hassana Hsein (H)

Univ. Bordeaux, Laboratoire de Pharmacie Galénique et Biopharmacie, CNRS, Arts et Metiers Institute of Technology, Bordeaux INP, INRAE, I2M Bordeaux, Talence, F-33400, France. Electronic address: hassana.hsein@u-bordeaux.fr.

Charbel Madi (C)

Univ. Bordeaux, Laboratoire de Pharmacie Galénique et Biopharmacie, CNRS, Arts et Metiers Institute of Technology, Bordeaux INP, INRAE, I2M Bordeaux, Talence, F-33400, France.

Vincent Mazel (V)

Univ. Bordeaux, Laboratoire de Pharmacie Galénique et Biopharmacie, CNRS, Arts et Metiers Institute of Technology, Bordeaux INP, INRAE, I2M Bordeaux, Talence, F-33400, France.

Pierre Tchoreloff (P)

Univ. Bordeaux, Laboratoire de Pharmacie Galénique et Biopharmacie, CNRS, Arts et Metiers Institute of Technology, Bordeaux INP, INRAE, I2M Bordeaux, Talence, F-33400, France.

Virginie Busignies (V)

Univ. Bordeaux, Laboratoire de Pharmacie Galénique et Biopharmacie, CNRS, Arts et Metiers Institute of Technology, Bordeaux INP, INRAE, I2M Bordeaux, Talence, F-33400, France.

Articles similaires

Animals Dietary Fiber Dextran Sulfate Mice Disease Models, Animal
Calcium Carbonate Sand Powders Construction Materials Materials Testing
Nanoparticles Needles Polylactic Acid-Polyglycolic Acid Copolymer Polyethylene Glycols Curcumin
Flurbiprofen Tablets Administration, Oral Drug Compounding Solubility

Classifications MeSH